H&E

Deep Bio's AI-based Antibody Optimization Platform Applied to Parkinson's Disease

Retrieved on: 
Friday, August 13, 2021

The R&D collaboration aims to find the most optimized antibody by applying Deep Bio's AI technology to promising candidates.

Key Points: 
  • The R&D collaboration aims to find the most optimized antibody by applying Deep Bio's AI technology to promising candidates.
  • The antibody under study, if successful, has the potential to become an effective treatment option for patients with Parkinson's disease.
  • Utilizing our AI-based algorithm will dramatically reduce the time and cost for drug optimization," said the CEO of Deep Bio.
  • Deep Bio Inc. is an AI biotech company with in-house expertise in deep learning, pathology, life sciences, and pharmacotherapeutics.

H&E Equipment Services Reports Quarterly Cash Dividend

Retrieved on: 
Wednesday, August 11, 2021

H&E Equipment Services, Inc. (NASDAQ: HEES) today announced that its Board of Directors declared a regular quarterly cash dividend to be paid to its stockholders.

Key Points: 
  • H&E Equipment Services, Inc. (NASDAQ: HEES) today announced that its Board of Directors declared a regular quarterly cash dividend to be paid to its stockholders.
  • The Company announced a quarterly cash dividend of $0.275 per share of common stock to be paid on September 17, 2021 for stockholders of record as of the close of business on August 27, 2021.
  • The Company is focused on heavy construction and industrial equipment and rents, sells and provides parts and services support for four core categories of specialized equipment: (1) hi-lift or aerial platform equipment; (2) cranes; (3) earthmoving equipment; and (4) material handling equipment.
  • By providing equipment rental, sales, on-site parts, repair and maintenance functions under one roof, the Company is a one-stop provider for its customers varied equipment needs.